Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

This is a study to assess the safety and bioeffect of REGN1033 (SAR391786) in healthy volunteers.

Key facts

Study ID

NCT01910220

Run by

Regeneron Pharmaceuticals

People needed

125

Starts

2013-08-01

Expected to finish

2014-10-01

Last updated by the study team

2014-11-10

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and postmenopausal females aged 60 years and older with no significant health issues or clinically significant abnormal laboratory values.
• Low activity lifestyle
• Diet and exercise adherence

You may not qualify if…

• Significant concomitant illness such as, but not limited to cardiac, renal, rheumatologic, gastrointestinal, hematological, skeletal/muscular, neurologic, psychiatric, endocrine, metabolic or immunological disease.
• Participation in any clinical trial within 6 months prior to screening.
• Hospitalization, immobilization, or major surgical procedure requiring general anesthesia within 6 months prior to screening, or any planned surgical procedures during the study period.
• Limb amputation (except for toes) and/or any fracture within 6 months.
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial and not all inclusion/ exclusion criteria are listed.

Where it is running

• Study site — Gainesville, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Boston, Massachusetts, United States
• Study site — St Louis, Missouri, United States
• Study site — Athens, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.